Compounds > chitosan
Page last updated: 2024-08-25

chitosan and Dysplastic Nevus Syndrome, Hereditary

chitosan has been researched along with Dysplastic Nevus Syndrome, Hereditary in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Abdi, F; Arkan, E; Eidizadeh, M; Gamizgy, YH; Mansouri, K; Naseriyeh, T; Valipour, E1
Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW1
Barone, A; Cabral, C; Mare, R; Mendes, M; Paolino, D; Vitorino, C1
Jacques, AV; Lemos-Senna, E; Loch-Neckel, G; Mazzarino, L; Moccelin, B; Santos-Bubniak, L; Santos-Silva, MC1

Other Studies

4 other study(ies) available for chitosan and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
The possibility of angiogenesis inhibition in cutaneous melanoma by bevacizumab-loaded lipid-chitosan nanoparticles.
    Drug delivery and translational research, 2023, Volume: 13, Issue:2

    Topics: Angiogenesis Inhibitors; Bevacizumab; Chitosan; Humans; Lipids; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Skin Neoplasms

2023
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
    Carbohydrate polymers, 2020, Sep-15, Volume: 244

    Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; Humans; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Oligosaccharides; Skin Neoplasms

2020
Hybrid Nanostructured Films for Topical Administration of Simvastatin as Coadjuvant Treatment of Melanoma.
    Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:10

    Topics: Adhesives; Administration, Topical; Animals; Cell Line; Chitosan; Chlorocebus aethiops; COS Cells; Drug Carriers; Drug Liberation; Humans; Lipids; Melanoma; Melanoma, Cutaneous Malignant; Nanoparticles; Nanostructures; Particle Size; Permeability; Simvastatin; Skin; Skin Absorption; Skin Neoplasms

2019
Orally Administered Chitosan-Coated Polycaprolactone Nanoparticles Containing Curcumin Attenuate Metastatic Melanoma in the Lungs.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:10

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Chitosan; Curcumin; Female; Intestinal Absorption; Matrix Metalloproteinase 2; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasm Metastasis; Polyesters; Skin Neoplasms

2015